Organization | Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey

Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey Report issue

Academic/Hospital Phase 3

Founded: Istanbul Turkey

Organization Overview

First Clinical Trial

2017

NCT03747900

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2023

Timeline

NOW

Alternative names

Haydarpasa Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey | Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey

Active Ingredients

Drugs in Phase 3 Trials (4)

azithromycin (zithromax) (1 trial)

favipiravir (1 trial)

hydroxychloroquine (plaquenil) (1 trial)

ivermectin (stromectol) (1 trial)

Drugs in Other Trials (7)

betamethasone (celestone) (2 trials)

lidocaine (xylocaine) (1 trial)

methylprednisolone (medrol) (2 trials)

onabotulinumtoxinA (Botox) (1 trial)

ozone (2 trials)

prilocaine (citanest) (1 trial)

vitamin d3 (1 trial)

Indications

Overview

Highest Phase: Phase 3
# of Trials: 9
# of Trial APIs: 11